Yuanbao Inc. - Sponsored ADR (NASDAQ:YB - Get Free Report)'s stock price dropped 4% on Wednesday . The company traded as low as $19.52 and last traded at $20.48. Approximately 109,924 shares traded hands during trading, an increase of 27% from the average daily volume of 86,250 shares. The stock had previously closed at $21.34.
Analyst Ratings Changes
Separately, Wall Street Zen cut Yuanbao from a "buy" rating to a "hold" rating in a research note on Sunday.
View Our Latest Stock Report on YB
Yuanbao Price Performance
Yuanbao (NASDAQ:YB - Get Free Report) last posted its quarterly earnings data on Thursday, June 5th. The company reported $0.89 EPS for the quarter. The firm had revenue of $133.68 million for the quarter.
About Yuanbao
(
Get Free Report)
Our mission is to protect health and well-being through technology. We are a leading technology-driven online insurance distributor in China. We take pride in pioneering the seamless integration of insurance with cutting-edge technologies, and have constructed a highly efficient full consumer service cycle engine.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Yuanbao, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Yuanbao wasn't on the list.
While Yuanbao currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
